BBNX vs MTB · rev $100.3M vs P/E 12, rev $860.0M
Beta Bionics, Inc. Common Stock (BBNX) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
BBNX currently screens at market cap $640.8M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the BBNX and MTB stock pages for the full models.
Not investment advice.